1-12 of 12
Maria J. Calasanz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Marta Fernandez-Mercado, Andrea Pellagatti, Janet Perry, Cristina Fernandez-Santamaria, Maria J. Calasanz, Maria J. Larrayoz, Maria D. Odero, Sally Killick, James S. Wainscoat, Jacqueline Boultwood
Journal: Blood
Blood (2010) 116 (21): 2940.
https://doi.org/10.1182/blood.V116.21.2940.2940
Published: 2010
Journal Articles

SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

Ion Cristóbal, Francisco J. Blanco, Laura Garcia-Orti, Nerea Marcotegui, Carmen Vicente, José Rifon, Francisco J. Novo, Eva Bandres, María J. Calasanz, Carmelo Bernabeu, María D. Odero
Journal: Blood
Blood (2010) 115 (3): 615–625.
https://doi.org/10.1182/blood-2009-06-227363
Published: 2010
Includes: Supplemental data
Journal Articles

MYB Overexpression Is Directly Involved in Acute Myeloid Leukemia Pathogenesis and Could Constitute a New Therapeutic Target for Patients with Aberrant Expression of This Gene.

Carmen Vicente, Ph.D., Ana Conchillo, Ph.D., Daphnie Pauwels, BSc, Iria Vazquez, Ph.D., Laura Garcia-Orti, BSc, Maria J. Calasanz, Ph.D., Idoya Lahortiga, Ph.D., Jan Cools, Ph.D., Maria D. Odero, MD, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2402.
https://doi.org/10.1182/blood.V114.22.2402.2402
Published: 2009
Journal Articles

Epigenomic Analysis of Acute Myeloid Leukemia Identifies Specific Patterns and Markes with Clinical and Biological Relevance.

Sara Alvarez, MD, PhD, Javier Suela, PhD, Ana Valencia, MD, Agustin Fernandez, PhD, Mark Wunderlich, MS, Xabier Agirre, PhD, Felipe Prosper, MD, Jose Ignacio Martin-Subero, PhD, Alba Maiques, MSc, Francesco Acquadro, MSc, Sandra Rodriguez-Perales, PhD, Maria J. Calasanz, PhD, Jose Roman-Gomez, MD, Reiner Siebert, MD, PhD, James C. Mulloy, PhD, José Cervera, MD, PhD, Miguel A. Sanz, MD, PhD, Manel Esteller, MD, PhD, Juan C Cigudosa, PhD
Journal: Blood
Blood (2009) 114 (22): 2394.
https://doi.org/10.1182/blood.V114.22.2394.2394
Published: 2009
Journal Articles

Prevalence of EVI1 Overexpression and Its Impact on Diagnosis and Prognosis in Acute Myeloid Leukemia: A Study of 490 Patients from the Spanish Group of Myeloid Malignancies of the RTICC.

Iria Vazquez, BSc, José Cervera, MD, PhD, Maria Gomez-Benito, Ph.D., Nerea Marcotegui, BSc, Miren Maicas, BSc, Ana Conchillo, Ph.D., Ana Valencia, Ph.D., Eva Lumbreras, Ph.D., Salut Brunet, MD, Maria T. Gómez-Casares, MD, Ph.D., Jesus-Maria Hernandez-Rivas, MD, Ph.D., Maria J. Calasanz, PhD, Jorge Sierra, MD, PhD, Maria D. Odero, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1515.
https://doi.org/10.1182/blood.V112.11.1515.1515
Published: 2008
Journal Articles

Risk-adapted treatment of acute promyelocytic leukemia with all- trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

Brief Report
Miguel A. Sanz, Pau Montesinos, Edo Vellenga, Consuelo Rayón, Javier de la Serna, Ricardo Parody, Juan M. Bergua, Angel León, Silvia Negri, Marcos González, Concha Rivas, Jordi Esteve, Gustavo Milone, José D. González, Elena Amutio, Salut Brunet, J. García-Laraña, Dolors Colomer, María J. Calasanz, Carmen Chillón, Eva Barragán, Pascual Bolufer, Bob Lowenberg
Journal: Blood
Blood (2008) 112 (8): 3130–3134.
https://doi.org/10.1182/blood-2008-05-159632
Published: 2008
Journal Articles

CML and Imatinib Mesylate: Response Related to Karyotype.

Araceli Rubio-Martinez, MD, PhD, Valle Recasens, MD, Maria D. Odero, MDPhD, Daniel Rubio-Felix, MDPhD, Maria J. Calasanz, MDPhD, Pilar Mayayo, MD, Manuel Giralt, MDPhD, Pilar Giraldo, MDPhD
Journal: Blood
Blood (2005) 106 (11): 4866.
https://doi.org/10.1182/blood.V106.11.4866.4866
Published: 2005
Journal Articles

Genetic Aberrations and Response to Fludarabine as First Line Treatment in a Serie of B-CLL Patients.

Pilar Giraldo, MD, PhD, Araceli Rubio-Martinez, MDPhD, Valle Recasens, MD, Mikel Valganon, MD, Paz Latre, MD, Daniel Rubio-Felix, MDPhD, Maria J. Calasanz, MDPhD, Maria D. Odero, MDPhD
Journal: Blood
Blood (2005) 106 (11): 2131.
https://doi.org/10.1182/blood.V106.11.2131.2131
Published: 2005
Journal Articles

GATA2 Is Overexpressed in 46% of Patients with AML and Normal Karyotype. The Mutational Pattern FLT3-ITD/GATA2/WT1 Could Define a Group of Patients with Normal Karyotype and AML-M1 Subtype.

Idoya Lahortiga, PhD, Iria Vazquez, BSc, Nerea Marcotegui, BSc, Eva Bandres, PhD, Raquel Malumbres, PhD, Maria J. Larrayoz, BSc, Carmen Vicente, BSc, Jose Cervera, MD, PhD, Jesus M. Hernandez, MD, PhD, Jesus Garcia-Foncillas, MD, PhD, Maria T. Ardanaz, MD, Filomena Floristan, MD, Maria J. Calasanz, PhD, Maria D. Odero, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2378.
https://doi.org/10.1182/blood.V106.11.2378.2378
Published: 2005
Journal Articles

A Gain of Function Mutation in JAK2 Is Frequently Found in Patients with AML-M2 and Normal Karyotype.

Nerea Marcotegui, BSc, Idoya Lahortiga, PhD, Iria Vazquez, BSc, Jose L. Vizmanos, PhD, Ion Cristobal, BSc, Cristina Ormazabal, BSc, Eva Bandres, PhD, Maria J. Larrayoz, BSc, Carmen Vicente, BSc, Maria J. Calasanz, PhD, María D. Odero, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2366.
https://doi.org/10.1182/blood.V106.11.2366.2366
Published: 2005
Journal Articles

Additional Chromosome Abnormalities Have No Prognostic Value in Acute Promyelocytic Leukemia Patients Treated with Simultaneous ATRA and Anthracycline-Based Chemotherapy: An Update of the APL96 and APL99 Pethema Protocols.

Jose Cervera, MD, Guillermo Martin, MD, Jesus M. Hernandez, MD, Edo Vellenga, MD, Maria J. Calasanz, MD, Jose A. Martinez-Climent, MD, Elisa Luño, MD, Maria T. Ferro, MD, Consuelo Rayon, MD, Marcos Gonzalez, MD, Mar Tormo, MD, Concha Rivas, MD, Elena Amutio, MD, Javier de la Serna, MD, Jose D. Gonzalez-San Miguel, MD, Juan Bergua, MD, Angel Leon, MD, Joaquin Diaz-Mediavilla, MD, Jose Garcia-Laraña, MD, Jordi Esteve, MD, Miguel A. Sanz, on behalf of the PETHEMA Cooperative Group
Journal: Blood
Blood (2004) 104 (11): 2019.
https://doi.org/10.1182/blood.V104.11.2019.2019
Published: 2004
Journal Articles

Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia

Clinical Trials & Observations
Jose Roman-Gomez, Antonio Jimenez-Velasco, Juan A. Castillejo, Xabier Agirre, Manuel Barrios, German Navarro, Francisco J. Molina, Maria J. Calasanz, Felipe Prosper, Anabel Heiniger, Antonio Torres
Journal: Blood
Blood (2004) 104 (8): 2492–2498.
https://doi.org/10.1182/blood-2004-03-0954
Published: 2004